series-b
Stage
About
Lykos Therapeutics develops investigational psychedelic-based therapies, including MDMA-assisted treatment, focusing primarily on mental health conditions such as post-traumatic stress disorder (PTSD), and runs clinical trials along with FDA-authorized expanded access programs.
Explore Lykos Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.